Markedly prolonged disease course, with breakthrough seizures, in a glioma with an isolated IDH1 mutation.

Drumm, Michael; Templer, Jessica W; Tate, Matthew; Jennings, Lawrence; Horbinski, Craig

Drumm, Michael; Templer, Jessica W; Tate, Matthew; Jennings, Lawrence; Horbinski, Craig.

Afiliación

Drumm M; Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Templer JW; Department of Neurology, Northwestern University, Chicago, Illinois, USA.
Tate M; Department of Neurological Surgery, Northwestern University, Chicago, Illinois, USA.
Jennings L; Department of Pathology, Northwestern University, Chicago, Illinois, USA.
Horbinski C; Department of Neurological Surgery, Northwestern University, Chicago, Illinois, USA.

Neurooncol Adv ; 4(1): vdac004, 2022.

Article en En | MEDLINE | ID: mdl-35128400

Palabras clave

IDH1 mutation; recurrence; seizure; survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google